Weakened immunity: Impaired T-cell function and macrophage activity
At 2.4 mg, the target dose for phase 3 trials, the benefit-to-risk ratio appeared optimal
These emerging applications offer researchers opportunities to study senescence contributions to neurodegeneration and develop novel approaches for studying brain aging and neurodegenerative disease mechanisms
Topical dihydrotestosterone to treat micropenis secondary to partial androgen insensitivity syndrome (PAIS) before, during, and after puberty A case series
Brain fog and slower recall can stem from many causes, including hormone imbalances, nutrient deficiencies, chronic inflammation, sleep disruption, or age-related neurological change
Some users report temporary skin purgingincreased breakouts or skin sensitivity in weeks 2-4as damaged tissue remodeling accelerates